Back This Medical AI Tech
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
One Tech Tip: How to clean your computer, earbuds and smartphone
LONDON (AP) — Smartphones, laptops, headphones and other electronic devices are essential for work and play in our daily lives. But all that time spent typing, scrolling or listening also means our devices gradually accumulate grime that needs to be cleaned off.
Making healthy snacks a habit when afternoon energy slumps strike at work
NEW YORK (AP) — When Claire Paré was a classroom teacher, working in a setting where every minute, down to the bathroom breaks, was scheduled, she brought granola bars, and protein shakes to school so she’d be prepared when hunger hits.
Palantir Makes a Move - Now Look At the Chart - Ad
One under-the-radar company just partnered with Palantir to take autonomous security to the next level.
House Republicans race toward a final vote on Trump's tax bill, daring critics to oppose
WASHINGTON (AP) — Republican leaders in the House are sprinting toward a Wednesday vote on President Donald Trump's , determined to seize momentum from a in the Senate while essentially daring members to defy their party's leader and vote against it.
Business News Digest
AP Business Digest
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
FDA names former pharmaceutical company executive to oversee US drug program
WASHINGTON (AP) — The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the latest in a string of leadership changes at the agency.
Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths
WASHINGTON (AP) — Drugmaker said late Friday it won't comply with a request from the Food and Drug Administration to halt all shipments of receiving one of its treatments for muscular dystrophy.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Why Is MEI Pharma Stock Soaring On Friday?
MEI Pharma, Inc. (NASDAQ:MEIP) stock is trading higher on Friday, with a session volume of 35.64 million compared to the average volume of 29.8K, as per data from Benzinga Pro.
Trump says Coke will shift to cane sugar. But increasingly, shoppers want no sugar in their sodas
The debate over whether should use high-fructose corn syrup or in its signature soda obscures an important fact: Consumers are increasingly looking for Coke with no sugar at all.
U.S. Military Flagged This Metal as Critical-Here's Why That Matters Now - Ad
Antimony is back on the Pentagon's radar, and America is scrambling for domestic supply. Early Investors are looking to ride the next strategic metals wave.
Republicans are considering changes to Trump's request for $9.4 billion in spending cuts
WASHINGTON (AP) — Senate Republicans were exploring changes Tuesday to President Donald Trump's to cancel $9.4 billion in previously approved spending targeted by his Department of Government Efficiency, signaling potential difficulties ahead of an important test vote.
FDA Delays Approval For Ultragenyx's Gene Therapy, But Not A Dealbreaker, Says Analyst
Ultragenyx's UX111 gene therapy faces FDA delay due to facility issues; analysts adjust price targets amid uncertain resubmission timeline.
Palantir's AI Is Going Physical - Ad
The next wave of security AI is happening now. Palantir just joined forces with a company already doing the work.
Beat the heat with these cooling gadgets and wearables
You can only sit in front of the fridge with the door open for so long.
Breakfast cereal sales declined for decades before Kellogg's sale to Italian company
Breakfast cereal could use a lucky charm.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
UN says if US funding for HIV programs is not replaced, millions more will die by 2029
LONDON (AP) — Years of programs has reduced the number of people killed by the disease to the lowest levels seen in more than three decades, and provided for some of the world’s most vulnerable.
Rhythm Pharma's Oral Drug For Rare Obesity Shows Promise
Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 with regulators.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the July 1st funding window closes.
Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday?
ZyVersa gains FDA approval for emergency use of VAR 200 in a rare kidney disease case; stock jumps on high trading volume and regulatory momentum.
Swiss medicines authority issues first approval for antimalarial drug for treatment of infants
GENEVA (AP) — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of lives — nearly all in Africa — each year.
This WWII Metal Is Quietly Powering America's Next Defense Build-up - Ad
Used in armor, ammo, and batteries... antimony helped win World War II. Now, with China tightening control, one company may have found a new domestic source-just in time.
Business News Digest
AP Business Digest
Apogee Therapeutics' Eczema Drug Provides Rapid Itch Relief In Phase 2 Trial
Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B is ongoing.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Medicaid, food aid recipients worry about safety net cuts in bill sent to Trump
JEFFERSON CITY, Mo. (AP) — Supporters of the that Congress has sent to President Donald Trump say the changes to Medicaid, food aid and other programs will encourage personal responsibility and halt those scamming the system.
Nearly 368,000 pounds of Oscar Mayer turkey bacon recalled over possible listeria contamination
Nearly 368,000 pounds of Oscar Mayer turkey bacon products are being recalled over possible contamination with , federal health officials said Wednesday.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz
ASL demands Avadel replace its board over failures in marketing Lumryz and urging a review of strategic options
Thinking about taking a stab at IV therapy? Ask some questions first
IV therapy clinics are springing up around the country, touting quick ways to recover from a hangover or a hard workout. But doctors and regulators preach caution.
Palantir Makes a Move - Now Look At the Chart - Ad
One under-the-radar company just partnered with Palantir to take autonomous security to the next level.
France to ban smoking in parks, beaches, and near schools
PARIS (AP) — France has struggled to kick its . A new public health decree published Saturday aims to change that.
J.M. Smucker plans to remove artificial colors from its jams and other products by the end of 2027
J.M. Smucker Co. plans to from its products by the end of 2027.
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
Thailand starts banning the sale of cannabis without a prescription
BANGKOK (AP) — Thailand has started banning the sale of cannabis to those without a prescription, three years after becoming the first country in Asia to decriminalize the plant.
Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data
Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and showing good tolerability.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.